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This study was designed to investigate the inhibitory effects of Angelica polysaccharide (AP) on activation of mast cells and its
possible molecular mechanism. In our study, we determined the proinflammatory cytokines and allergic mediators in anti-DNP
IgE stimulated RBL-2H3 cells and found that AP (50, 100, and 200 𝜇g/mL) significantly decreased the release of histamine, 𝛽-
hexosaminidase, leukotrienes C4 (LTC4), IL-1, IL-4, TNF-𝛼, IL-6, and human monocyte chemotactic protein-1 (MCP-1/CCL2)
(𝑝 < 0.05). In addition, Ca2+ entry was inhibited by treatment with AP. AP also downregulated the protein expressions of p-Fyn,
p-Akt, p-P38, IL-4, TNF-𝛼, and NF-𝜅B p65 in both Fyn gene upregulated and normal RBL-2H3 cells (𝑝 < 0.05). Collectively, our
results showed that AP could inhibit the activation of mast cells via suppressing the releases of proinflammatory cytokines allergic
mediators, Gab2/PI3-K/Akt and Fyn/Syk pathways.
1. Introduction
Allergic disorders, such as eczema, allergic rhinitis, and
asthma, are generally considered as intractable diseases
threatening people’s health with an increasing prevalence in
recent years [1, 2]. There is increasing evidence that mast
cells play crucial roles in the development and pathogenesis
of allergic diseases [3, 4]. In addition, allergic disorders
are commonly caused by hypersensitive response to various
allergens, such as proteins, pollen, chemicals, dust, and
ultraviolet radiation [5]. Human’s immune system would
be sensitized after initial stimulation by an allergen. Thus,
when rechallenged by the same allergen, the mast cells
would be activated and degranulated; subsequently, various
proinflammatory cytokines and allergic mediators would be
released, leading to systemic allergic reactions [6, 7].
Angelica sinensis (Oliv.) Diels, belonging to the family
of Apiaceae, is one of the well-known and commonly used
traditional Chinese medicines. In traditional Chinese medi-
cine theory, A. sinensis is a widely and commonly used drug
for treating blood deficiency, inflammatory and gynecologi-
cal diseases, and so forth. Current research indicates that A.
sinensis is effective in the treatment of cardio- and cerebrovas-
cular and immune nervous systems diseases, and so forth
[8, 9]. In recent years, Angelica polysaccharide (AP) has been
identified as one of the important and active components of
A. sinensis. Increasing investigations have demonstrated that
the AP possesses a wide range of pharmacological activities
on the immune and circulatory system of humans including
antitumor activity, immunoregulatory effect, radioprotective
effect, and inhibition of platelet aggregation [10, 11].
As part of our continuing investigation on discovering
candidate agents fromTCMs, AP showed notable antiallergic
effect in vitro in our preliminary experiment. Therefore, our
present research was designed to systemically investigate
the inhibitory effects of AP on activation of mast cells and
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its possible molecular mechanism, which would provide a
scientific basis for the clinical use of AP to treat allergic
disorders.
2. Materials and Methods
2.1. Chemicals and Reagents. Angelica polysaccharide (AP)
was purchased from JRDUN Biotechnology Co. Ltd. (Shang-
hai, China); DMEM and fetal bovine serum (FBS) were
purchased from Gibco. Co. (NY, USA); Cell Counting Kit-8
(CCK-8) was purchased from Dojindo Biochem (Shanghai,
China); antidinitrophenol (DNP) IgE and DNP-HAS were
purchased from Sigma-Aldrich (MO, USA); Fluo-3 AM
reagents were purchased from Life Tech. Co. (CA, USA); rats
histamine, IL-1, TNF-𝛼, IL-6, LTC4, 𝛽-hexosaminidase, and
MCP-1/CCL2 ELISA kits were purchased from the Boster
Co. (Wuhan, China); p-Fyn and Fyn primary antibodies were
purchased from Abcam Co. (Cambridge, UK); p-Akt, Akt, p-
P38, P38, and NF-𝜅B p65 primary antibodies were purchased
from CST Co. (MA, USA); TNF-𝛼, IL-4, and GAPDH
primary antibodies were purchased from Santa Cruz Biotech.
(CA, USA); BCA protein kit and horseradish peroxidase-
(HPR-) conjugated secondary antibodies were purchased
from Beyotime Co. (Jiangsu, China); PVDF membrane was
purchased fromMillipore Biotech. (MA, USA).
2.2. Cell Culture and Cell Viability Assay. RBL-2H3 cells were
purchased from the American Type Culture Collection (MD,
USA) and were cultured in DMEM containing 10% (v/v)
heat-inactivated FBS, 100 IU/mL penicillin, and 100 𝜇g/mL
streptomycin at 37∘C in a humidified atmosphere with 5%
CO
2
.
Cell viability determination was carried out by using the
CCK-8 assay [12]. Briefly, RBL-2H3 cells (5× 104/100 𝜇L)were
seeded in 96-well plates and cultured at 37∘C for 24 h. Then,
100 𝜇L serum-free DMEM containing 10% CCK-8 reagents
(v/v) was added in each well, and cells were cultured for
1 h at 37∘C. Subsequently, optical density (OD) values were
determined at 450 nm by using a 96-well plate reader (DNM-
9602, Pulang New technology, Beijing, China).
2.3. Degranulation Assay in RBL-2H3 Cells. RBL-2H3 cells (2
× 105/well) were seeded in 24-well plates and stimulated with
anti-DNPIgE (100 ng/mL) for 12 h.Then, the culture solution
of RBL-2H3 cells was refreshed, and cells were treated with
AP (50, 100, and 200𝜇g/mL) and azelastine (used as positive
drugs, 30 𝜇g/mL) for 1 h. The cells were then washed with
Tyrode’s buffer three times followed by incubation with
DNP-HAS (20 ng/mL) for 30 and 120min, respectively. (1)
Then, for the cells incubated with DNP-HAS (20 ng/mL) for
30min, the supernatant of the cell mixture was collected and
the release of 𝛽-hexosaminidase, histamine, and LTC4 was
determined by using commercial ELISA kits. In addition,
the cells were also harvested for determining the releases of
𝛽-hexosaminidase and the inhibition of 𝛽-hexosaminidase
release was calculated. (2) For the cells incubated with DNP-
HAS (20 ng/mL) for 120min, the supernatant of the cell
mixture was collected, and IL-1, IL-4, TNF-𝛼, and CCL2 were
assayed by ELISA kits according to the instructions provided
by the supplier [7].
2.4. Determination of Intracellular Ca2+ Concentrations. The
concentration of Ca2+ was determined by using Fluo-3 AM
Calcium Kits according to the manufacturer’s instructions.
Briefly, RBL-2H3 cells were seeded into the 6-well culture
plate and treated with anti-DNP IgE. Subsequently, cells were
incubated with 1mL Fluo-3 AM for 1 h, and the fluorescent
intensity was determined by using the flow cytometer (Accuri
C6, BD, NJ, USA) [6].
2.5. Western Blot Assay. RBL-2H3 cells (2 × 105/well) were
seeded in 24-well plates and stimulated with anti-DNP IgE
(100 ng/mL) for 12 h. Then, the culture solution of RBL-
2H3 cells was refreshed, and cells were treated with AP
(50, 100, and 200𝜇g/mL) for 1 h and the cells were washed
with Tyrode’s buffer three times. Following this, cells were
incubated with DNP-HAS (20 ng/mL) for 10min and the
total proteins were extracted, and their concentration was
determined by BCA protein kit and 30 𝜇g total proteins were
separated by sodium dodecyl sulfate- (SDS-) polyacrylamide
gel electrophoresis (PAGE) and subsequently transferred to
a PVDF membrane. The transferred protein PVDF mem-
brane was probed with various primary antibodies, followed
by incubation with HPR-conjugated secondary antibodies.
Finally, chemiluminescence detection was used to visualize
the target protein bands. To normalize protein loading,
antibodies directed against GAPDH were used, and the
proteins expression levels were expressed as a relative value
to that of GAPDH.
2.6. Plasmid Construction and Transient Transfection. Fyn
upregulated RBL-2H3 cells were constructed by the JRDUN
Biotech. Co. (Shanghai, China). Briefly, the human Fyn gene
was subcloned into a lentiviral vector [pCDNA3.1 (+)] to
generate the lentiviral expression vector [pCDNA3.1 (+)-
Fyn]. The recombinant lentiviruses were then produced by
293 T cells following the cotransfection of pCDNA3.1 (+)-
Fyn. The resulting recombinant lentiviruses carrying Fyn
were used to infect RBL-2H3 cells. The Fyn expression in
untreated RBL-2H3 cells, cells treated with control vector
(MOCK group), and Fyn gene overexpressed RBL-2H3 cells
(Fyn-RBL-2H3) were detected by using real-time fluorogenic
PCR (qRT-PCR) and western blotting assay.
2.7. Real-Time Fluorogenic PCR Assays. RBL-2H3 cells were
harvested, and total RNA was extracted using Trizol reagent
(Invitrogen, USA). Total RNA was used for cDNA synthesis
of NF-𝜅B p65, TNF-𝛼, Fyn, IL-4, and GAPDH by reverse
transcription using qRT-PCR (ABI-7300, USA). All mRNA
primers were designed by Premier 5.0 and synthesized by
JRDun Biotech. (Shanghai, China). Primers used for the real-
time PCR are shown in Table 1. Reverse transcription was
performed according to the manufacturer’s recommendation
of the quantitative RT-PCR reaction kits (SYBR Green,
Thermo Fisher Scientific, Shanghai, China).
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Figure 1: Effects of AP on degranulation in RBL-2H3 cells stimulated with anti-DNP IgE. (a) Cytotoxicity of AP on RBL-2H3 cells. (b) Effects
of AP on histamine in RBL-2H3 cells. (c) Effects of AP on 𝛽-hexosaminidase in RBL-2H3 cells. (d) Effects of AP on LTC4 in RBL-2H3 cells.
Azelastine was used as positive control. Data were represented as mean ± SD (𝑛 = 6), ∗𝑝 < 0.05, and ∗∗𝑝 < 0.01, compared with control
group.
Table 1: Primers used in our real-time PCR experiment.
Genes Sequences
NF-𝜅B p65 F: 5
󸀠 AGACCTGGAGCAAGCCATTAG 3󸀠
R: 5󸀠 CGGACCGCATTCAAGTCATAG 3󸀠
TNF-𝛼 F: 5
󸀠 TGGCGTGTTCATCCGTTC 3󸀠
R: 5󸀠 CTACTTCAGCGTCTCGTGTG 3󸀠
Fyn F: 5
󸀠 ACCACCAAAGGTGCCTACTC 3󸀠
R: 5󸀠 ATGTAGTACCCGCCGTTGTC 3󸀠
IL-4 F: 5
󸀠 CCTTGCTGTCACCCTGTTC 3󸀠
R: 5󸀠 CTCGTTCTCCGTGGTGTTC 3󸀠
GAPDH F: 5
󸀠 GTCGGTGTGAACGGATTTG 3󸀠
R: 5󸀠 TCCCATTCTCAGCCTTGAC 3󸀠
2.8. Statistical Analyses. Data are presented as means ±
standard deviation. Statistically significant differences were
analyzed using two-tailed Student’s 𝑡-test; 𝑝 < 0.05 was
considered to represent a statistically significant difference.
3. Results
3.1. Effects of AP on Degranulation in RBL-2H3 Cells Stimu-
lated with Anti-DNP IgE. As can be seen from Figure 1(a),
cell viability assay showed no obvious cytotoxic effect of
AP on RBL-2H3 cells within the concentrations tested (0–
800 𝜇g/mL). Based on the results of cytotoxicity deter-
mination, the concentrations of 50, 100, and 200𝜇g/mL
without cytotoxicity were selected following the experi-
ments. Furthermore, our results showed that AP at con-
centrations of 50, 100, and 200𝜇g/mL possessed significant
histamine suppressing activities compared to the control
group, in a concentration-dependent manner (𝑝 < 0.01)
(Figure 1(b)). Additionally, AP (50, 100, and 200 𝜇g/mL)
also showed notable inhibitory effects on 𝛽-hexosaminidase
and leukotrienes C4 (LTC4) in a concentration-dependent
manner when compared to the control group (𝑝 < 0.05,
𝑝 < 0.01, and 𝑝 < 0.01, resp.) (Figures 1(c) and 1(d)).
Furthermore, compared to the control group, IL-1, TNF-
𝛼, IL-6, and human monocyte chemotactic protein-1 (MCP-
1/CCL2) were also significantly inhibited by AP (50, 100, and
200𝜇g/mL) with a concentration-dependent manner (𝑝 <
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Figure 2: Effects of AP on the releases of IL-1 (a), IL-4 (b), TNF-𝛼 (c), IL-6 (d), and MCP-1/CCL2 (e) in RBL-2H3 cells stimulated with
anti-DNP IgE.The azelastine was used as positive control. Data were represented as mean ± SD (𝑛 = 6), ∗𝑝 < 0.05, and ∗∗𝑝 < 0.01, compared
to control group.
0.01) (Figure 2). Besides, AP (50, 100, and 200 𝜇g/mL) also
significantly decreased the release of IL-4 (𝑝 < 0.05,𝑝 < 0.01,
and 𝑝 < 0.01, resp.), in a concentration-dependent manner.
3.2. Effects of AP on Ca2+ Entry in RBL-2H3 Cells Stimulated
with Anti-DNP IgE. In our present investigation, we also
determined Ca2+ entry in RBL-2H3 cells induced by anti-
DNP IgE by using Fluo-3-AM in conjunction with the
FLIPR system. Our present results showed that AP could
significantly decrease the Ca2+ influx in RBL-2H3 cells
stimulated with anti-DNP IgE at the concentrations of 50,
100, and 200𝜇g/mL (𝑝 < 0.01), compared to the control
group (Figure 3). Besides, we can also find an obvious
concentration-dependent manner for inhibiting Ca2+ influx
in the present study.
3.3. Effects of AP on Protein Expressions of p-Fyn, Fyn, p-Akt,
Akt, p-P38, P38, IL-4, TNF-𝛼, and NF-𝜅B p65. Furthermore,
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Figure 3: Effects of AP on Ca2+ entry in RBL-2H3 cells stimulated with anti-DNP IgE. The azelastine was used as positive control. Data are
represented as mean ± SD (𝑛 = 6), ∗∗𝑝 < 0.01, compared to control group.
by using western bolt assay, our study also investigates the
protein expressions of p-Fyn, Fyn, p-Akt, Akt, p-P38, P38, IL-
4, TNF-𝛼, and NF-𝜅B in RBL-2H3 cells stimulated with anti-
DNP IgE. The results indicate that the protein expressions
of p-Akt, p-P38, IL-4, and TNF-𝛼 were significantly down-
regulated by treatment with AP (50, 100, and 200 𝜇g/mL)
in a concentration-dependent manner (𝑝 < 0.01), when
compared to the control group. Similarly, treatment with AP
also downregulated the protein expressions of p-Fyn andNF-
𝜅B p65 (50, 100, and 200 𝜇g/mL) (𝑝 < 0.05, 𝑝 < 0.01, and
𝑝 < 0.01, resp.), when compared to the control group. In
contrast, no obvious difference was observed in the protein
expressions of Fyn, Akt, and P38 (𝑝 > 0.05), compared to the
control group (Figure 4).
3.4. Expression of Fyn in RBL-2H3 Cells after Transient
Transfection. In order to confirm the importance of Fyn gene
in the activation of mast cells, the Fyn upregulated RBL-2H3
cells were constructed by transient transfection. As can be
seen from Figure 5, after transient transfection, the Fyn gene
was significantly upregulated in theRBL-2H3 cells (𝑝 < 0.01),
compared to both untreated RBL-2H3 and MOCK groups
(Figure 5(a)). Furthermore, the results of ourwestern blotting
assay also demonstrated that Fyn protein was upregulated
after transient transfection (Figure 5(b)).
3.5. Effects of AP on mRNA Expressions of NF-𝜅B p65, IL-
4, and TNF-𝛼 in Upregulated RBL-2H3 Cells Stimulated with
Anti-DNP IgE. After the FynupregulatedRBL-2H3 cells were
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Figure 4: Effects of AP on protein expressions of p-Fyn, Fyn, p-Akt, Akt, p-P38, P38, IL-4, TNF-𝛼, and NF-𝜅B p65. Data are represented as
mean ± SD (𝑛 = 6), ∗𝑝 < 0.05, and ∗∗𝑝 < 0.01, compared with control group.
established, we determined the mRNA expressions of NF-𝜅B
p65, IL-4, and TNF-𝛼 in upregulated RBL-2H3 cells induced
by anti-DNP IgE. Our results indicated that the mRNA
expressions of NF-𝜅B p65, IL-4, and TNF-𝛼 genes in RBL-
2H3 cells were significantly increased in both untreated RBL-
2H3 cells (𝑝 < 0.01) andMOCK groups (𝑝 < 0.01). However,
treatment with AP (50, 100, and 200 𝜇g/mL) reversed these
increased mRNA expressions of NF-𝜅B p65 (𝑝 < 0.01), IL-
4 (𝑝 < 0.01), and TNF-𝛼 (𝑝 < 0.01), in a concentration-
dependent manner compared with the Fyn upregulated RBL-
2H3 cells. In addition, our results also demonstrated that
no obvious antiproliferation effect of AP (0–800 𝜇g/mL)
was found in the growth of Fyn upregulated RBL-2H3 cells
(Figure 6).
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Figure 6: Effects of AP on mRNA expressions of NF-𝜅B p65, IL-4, and TNF-𝛼 in upregulated RBL-2H3 cells stimulated with anti-DNP IgE.
MOCKmeans the cells treated with control vector, and Fyn-RBL-2H3 means Fyn gene upregulated RBL-2H3 cells, ∗∗𝑝 < 0.01, compared to
Fyn-RBL-2H3 cells.
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Figure 7: Effects of AP on protein expressions of p-Fyn, Fyn, p-Akt, Akt, p-P38, P38, IL-4, TNF-𝛼, and NF-𝜅B p65 in upregulated RBL-
2H3 cells stimulated with anti-DNP IgE. MOCKmeans the cells treated with control vector, and Fyn-RBL-2H3 means Fyn gene upregulated
RBL-2H3 cells, ∗∗𝑝 < 0.01, compared to Fyn-RBL-2H3 cells.
3.6. Effects of AP on Protein Expressions of p-Fyn, Fyn, p-Akt,
Akt, p-P38, P38, IL-4, TNF-𝛼, and NF-𝜅B p65 in Upregulated
RBL-2H3 Cells Stimulated with Anti-DNP IgE. Furthermore,
after treatment with AP (50, 100, and 200𝜇g/mL), we deter-
mined the protein expressions of p-Fyn, Fyn, p-Akt, Akt, p-
P38, P38, IL-4, TNF-𝛼, and NF-𝜅B p65 in upregulated RBL-
2H3 cells stimulated with anti-DNP IgE. As can be seen from
Figure 7, the p-Fyn, Fyn, p-Akt, p-P38, IL-4, TNF-𝛼, and
NF-𝜅B p65 were upregulated (𝑝 < 0.01), compared with
untreated RBL-2H3 cells. However, after treatment with AP
(50, 100, and 200𝜇g/mL), the expressions of p-Fyn, p-P38,
and NF-𝜅B p65 were downregulated significantly (𝑝 < 0.01)
in a concentration-dependent manner, compared to the Fyn-
RBL-2H3 cells. In addition, the AP (100 and 200 𝜇g/mL)
decreased the upregulated expressions of p-Akt, IL-4, and
TNF-𝛼 (𝑝 < 0.01), when compared to the Fyn-RBL-2H3 cells.
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4. Discussion
Eczema, one of the stubborn skin diseases with increasing
prevalence, is closely correlated to the immune functions
of human being. Currently, natural herbal medicines, such
as TCMs, have aroused considerable interest due to their
low toxicity and reliable therapeutic effects [12, 13]. Interest-
ingly, A. sinensis is one of the most commonly used herbal
medicines for treating eczema in China [14, 15]. However,
no systemic investigation reporting the active substances and
their therapeutic effect on eczema has been conducted. To the
best of our knowledge, this is the first systemic investigation
regarding inhibitory effect of Angelica polysaccharide (AP)
on activation of mast cells and its possible molecular mech-
anism. In our present research, the AP showed significant
inhibitory effect against the activation of RBL-2H3 cells. In
addition, our present results also indicated that downregulat-
ing Fyn gene might be a possible molecular mechanism for
responding to the activity of AP.
Previous researches reported that, after sensitization by
various allergens, the mast cells would be activated and
respond via degranulation [7, 16]. Subsequently, several
of proinflammatory cytokines and allergic mediators are
released, leading to immune response. Histamine and 𝛽-
hexosaminidase are commonly considered as the notable
markers in degranulation of mast cells [17]. Previous reports
have demonstrated that they would be elevated in plasma or
tissues in various allergic diseases. LTC4, IL-6, IL-1, MCP-
1/CCL2, and TNF-𝛼 play important roles in the development
of allergic diseases, and their release and synthesis could be
increased in various allergic diseases [18, 19]. In our present
study, we used the anti-DNP IgE, a commonly used allergen,
to sensitize the RBL-2H3 cells. Then, we determined the
releases of histamine, 𝛽-hexosaminidase, LTC4, and MCP-
1/CCL2 in RBL-2H3 cells. Besides, mast cell degranulation
and histamine production are Ca2+ dependent, and Ca2+
entry activates the degranulation of mast cells [7, 20].
Our present results showed that AP possessed significantly
inhibitory effects on releases of proinflammatory cytokines,
allergic mediators, and Ca2+ entry in RBL-2H3 cells stimu-
lated with anti-DNP IgE, indicating that AP could effectively
inhibit the degranulation and activation of mast cells. Alle-
viating the inflammatory reactions would be beneficial for
controlling the allergic symptoms. Our results also revealed
that AP treatment could inhibit the expressions of some
crucial inflammatory pathway cytokines including IL-1, IL-6,
TNF-𝛼, and NF-𝜅B p65.
Fyn is a crucial signaling molecule for activation of mast
cells stimulated by various antigens. Increasing reports have
demonstrated that Gab2/PI3-K/Akt and Fyn/Syk pathway
plays an essential role in the development of allergic diseases
[21, 22]. Interestingly, in our present study, we also found
thatAP could downregulate phosphorylated Fyn in anti-DNP
IgE stimulated RBL-2H3 cells. Furthermore, the phosphory-
lated downstream signaling molecules Gab2/PI3-K/Akt and
Fyn/Syk pathway in anti-DNP IgE stimulated RBL-2H3 cells,
including p-Akt and p-P38, were also downregulated. Thus,
we proposed that the Fyn might be a potential molecular
mechanism of AP for treating allergic diseases. To confirm
our hypothesis, the gene upregulated RBL-2H3 cells were
constructed by transient transfection. Importantly, similar
results were also obtained in the Fyn upregulated RBL-2H3
cells stimulated with anti-DNP IgE. Our results showed that
the AP treatment could downregulate the related cytokines
and proteins in inflammatory pathway and essential proteins
in Gab2/PI3-K/Akt and Fyn/Syk pathways.
5. Conclusions
In conclusion, our present investigation demonstrated that
AP could inhibit the releases of proinflammatory cytokines
and allergic mediators. In addition, our results also demon-
strated that AP downregulated the related cytokines and
proteins in inflammatory pathway and essential proteins in
Gab2/PI3-K/Akt and Fyn/Syk pathways. Collectively, our
results suggested that AP could inhibit the activation of mast
cells.
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